Patents Assigned to X-NUCLEAR DIAGNOSTICS GMBH
  • Patent number: 11701439
    Abstract: The invention relates to compounds according to the general formula (I) or a pharmaceutically acceptable salt of an inorganic or organic acid, a hydrate, a stereoisomer or a solvate thereof, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 being selected independently of one another from hydrogen and alkoxy. The compounds of formula (I) as ligands are suitable for the production of radioactively labelled 68Ga, 64Cu, 67Ga, 111In or 99mTc complexes. The invention further relates to a method for producing the compounds of formula (I) and the radioactively labelled complexes and to the use of the radioactively labelled complexes in imaging methods, such as PET/CT, in particular of the liver.
    Type: Grant
    Filed: December 10, 2018
    Date of Patent: July 18, 2023
    Assignee: X-NUCLEAR DIAGNOSTICS GMBH
    Inventors: Martin Freesmeyer, Julia Greiser